RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 70 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,024,000 | -39.4% | 184,772 | +5.8% | 0.00% | -100.0% |
| Q4 2021 | $1,691,000 | -44.1% | 174,650 | +20.7% | 0.00% | 0.0% |
| Q3 2021 | $3,024,000 | -16.2% | 144,726 | -2.1% | 0.00% | 0.0% |
| Q2 2021 | $3,607,000 | -14.6% | 147,792 | -7.3% | 0.00% | 0.0% |
| Q1 2021 | $4,226,000 | +212.1% | 159,493 | -10.6% | 0.00% | – |
| Q4 2020 | $1,354,000 | +50.9% | 178,472 | -0.4% | 0.00% | – |
| Q3 2020 | $897,000 | +6.9% | 179,217 | +27.8% | 0.00% | – |
| Q2 2020 | $839,000 | -3.9% | 140,246 | -28.5% | 0.00% | – |
| Q1 2020 | $873,000 | -52.9% | 196,201 | +0.6% | 0.00% | -100.0% |
| Q4 2019 | $1,853,000 | +78.3% | 195,059 | +47.4% | 0.00% | – |
| Q3 2019 | $1,039,000 | -47.2% | 132,338 | +5.7% | 0.00% | -100.0% |
| Q2 2019 | $1,969,000 | – | 125,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abbot Financial Management, Inc. | 1,411,775 | $25,243,000 | 11.48% |
| Flagship Pioneering Inc. | 38,506,526 | $688,497,000 | 7.21% |
| Artal Group S.A. | 4,155,625 | $74,303,000 | 1.66% |
| HARBOURVEST PARTNERS LLC | 986,878 | $17,645,000 | 1.66% |
| Nan Fung Group Holdings Ltd | 56,768 | $1,015,000 | 0.32% |
| Lombard Odier Asset Management (Switzerland) SA | 245,013 | $4,381,000 | 0.27% |
| Bellwether Advisors, LLC | 29,383 | $525,000 | 0.18% |
| PDT Partners, LLC | 65,991 | $1,180,000 | 0.08% |
| Virtus ETF Advisers LLC | 7,478 | $134,000 | 0.06% |
| HITE Hedge Asset Management LLC | 24,911 | $445,000 | 0.06% |